Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Not Confirmed
Not Confirmed
01-03 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
01-03 April, 2025
Peptide-Based Therapeu...Peptide-Based Therapeutics Summit
Industry Trade Show
Not Confirmed
01-03 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
18 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/rhovac-board-member-resigns-due-to-health-reasons-301652079.html
30 May 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/rhovac-prostate-cancer-trial/
10 May 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/rhovac-ab-announces-database-lock-in-its-clinical-phase-iib-trial-of-onilcamotide-301544454.html
09 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/another-clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301440945.html
05 Oct 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/rhovac-presents-3-year-follow-up-results-of-the-phase-iii-study-in-prostate-cancer-301392659.html
09 Jul 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/clean-interim-safety-review-of-rhovacs-clinical-phase-iib-study-in-prostate-cancer-301328656.html
ABOUT THIS PAGE